Friday, Oct 4, 2024 · SEC filings

What the smart money revealed on Oct 4

Real insider buys14insiders · $19.3M
Real insider sales43insiders · $56M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

312 insider filings came in. We hid 43 planned (10b5-1) sellers and 194 people whose filings were routine, like grants and tax withholding.

trending_up

RDE (GIFT) CFO Steve Handy bought $9.44M

2,221 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Oct 3
$9.44M
trending_up

Cliffwater Corporate Lending Fund (CCLFX) President/Interested Trustee Stephen Nesbitt bought $5M

459,137 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Sep 13
$5M
trending_up

Cartesian Therapeutics (RNAC) Director Timothy Springer bought $4.29M

205,721 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 8 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 1 of 8 beat Traded Oct 2–4
$4.29M
trending_up

Armour Residential REIT (ARR) Chairman of the Board Daniel Staton bought $199K

10,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Oct 3
$199K
trending_down

AutoZone (AZO) Executive Chairman William Rhodes III sold $41.3M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 40,321 shares directly.

Real sale Form 4 Traded Oct 2–3
$41.3M
trending_down

Lowe's Companies (LOW) EVP Seemantini Godbole sold $7.12M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 30,159 shares directly.

Real sale Form 4 Traded Oct 3
$7.12M
trending_down

TD SYNNEX (SNX) Hyve Solutions Executive Dennis Polk sold $1.83M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 134,706 shares directly.

Real sale Form 4 Traded Oct 2
$1.83M
Show 10 more real buys
Show 40 more real sales
LOW Lowe's Companies · EVP Joseph McFarland · Traded Oct 3
$1.08M
MDB MongoDB · President and CEO Dev Ittycheria · Traded Oct 2
$911K
TWST Twist Bioscience · CEO Emily Leproust · Traded Oct 2
$588K
CNXC Concentrix · President and CEO Christopher Caldwell · Traded Oct 4
$518K
MDB MongoDB · COO and CFO Michael Gordon · Traded Oct 2
$483K
PG Procter & Gamble · CEO - Beauty R. Alexandra Keith · Traded Oct 3
$346K
BPMC Blueprint Medicines · President Fouad Namouni · Traded Oct 3
$324K
TWST Twist Bioscience · President and COO Patrick Finn · Traded Oct 2
$297K
AMBA Ambarella · VP Christopher Day · Traded Oct 3
$168K
TWST Twist Bioscience · SVP of Human Resources Paula Green · Traded Oct 2
$143K
TWST Twist Bioscience · Officer Dennis Cho · Traded Oct 2
$134K
SEMR SEMrush · CEO Oleg Shchegolev · Traded Oct 2
$127K
PRSU Viad · Director Denise Coll · Traded Nov 1
$85.8K
SEMR SEMrush · COO Vitalii Obishchenko · Traded Oct 2
$74.4K
BCYC Bicycle Therapeutics · CEO Kevin Lee · Traded Oct 3
$71.5K
SEMR SEMrush · Chief Marketing Officer Andrew Warden · Traded Oct 2
$58.2K
SEMR SEMrush · President Eugenie Levin · Traded Oct 2
$53.5K
SIBN Si-Bone · CFO Anshul Maheshwari · Traded Oct 2
$44.9K
MDB MongoDB · Chief Accounting Officer Thomas Bull · Traded Oct 2
$39.5K
NTLA Intellia Therapeutics · VP Michael Dube · Traded Oct 2
$38.2K
XYZ Block · Chief Legal Officer Chrysty Esperanza · Traded Oct 2
$33.8K
CPNG Coupang · Officer Pranam Kolari · Traded Oct 2
$23.2K
BCYC Bicycle Therapeutics · Chief Business Officer Nigel Crockett · Traded Oct 3
$21.6K
BCYC Bicycle Therapeutics · CTO Michael Skynner · Traded Oct 3
$21.6K
BCYC Bicycle Therapeutics · COO Alistair Milnes · Traded Oct 3
$21.6K
SEMR SEMrush · Director Dmitry Melnikov · Traded Oct 2
$19.2K
ALGT Allegiant Travel · COO Keny Wilper · Traded Oct 4
$16.6K
GUG Guggenheim Active Allocation Fund · Director Randall Barnes · Traded Oct 3
$8.22K
BCYC Bicycle Therapeutics · Chief Prod and Supply Chain OFF Michael Hannay · Traded Oct 3
$5.5K
SDOT Sadot Group · Chief Investment Officer Kevin Mohan · Traded Oct 2
$4.34K
SDOT Sadot Group · CEO Michael Roper · Traded Oct 2
$4.34K
WYY Widepoint · COO Todd Dzyak · Traded Oct 1
$3.6K
BCYC Bicycle Therapeutics · Chief Accounting Officer Travis Thompson · Traded Oct 3
$3.41K
ASMB Assembly Biosciences · CEO and President Jason Okazaki · Traded Oct 3
$2.92K
ASMB Assembly Biosciences · Chief Manufacturing Officer Nicole White · Traded Oct 3
$2.33K
SDOT Sadot Group · CFO Jennifer Black · Traded Oct 2
$2.18K
KLRS Allovir · CEO Diana Brainard · Traded Oct 3
$1.21K
KLRS Allovir · Officer Vikas Sinha · Traded Oct 3
$761
KLRS Allovir · General Counsel Edward Miller · Traded Oct 3
$305
KLRS Allovir · Chief Accounting Officer Brett Hagen · Traded Oct 3
$244

13F season

Holdings as of Sep 30, 2024 are due Nov 14

58 funds have filed so far. 54 filed for the quarter before.

Biggest real insider buys, Sep 28–Oct 4

Open-market buys by officers and directors, filed in the 7 days up to Oct 4.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist